MediciNova, Inc. (MNOV) Stock

MediciNova, Inc. (MNOV) is a Healthcare stock trading at $1.32 (as of 2026-06-18), with a market capitalization of $66.94M and a trailing P/E of -5.7. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

MediciNova, Inc. is a biopharmaceutical company developing small-molecule therapeutics for serious diseases with unmet needs, with an emphasis on conditions addressed in the United States. Its pipeline includes MN-166 (ibudilast), MN-221 (bedoradrine), MN-001 (tipelukast), and MN-029 (denibulin), and it has collaboration arrangements with multiple pharmaceutical companies.

Valuation — source: SEC EDGAR (first-party)
Price$1.32
Market Cap$66.94M
P/E Ratio-5.7
EV / EBITDA-2.9
Price / Book1.65
Price / Sales158.60
DCF Value (model)$-2.77
DCF Upside vs Price-309.8%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$409657.00
Net Margin-2928.8%
Return on Equity-29.7%
Current Ratio9.09
Financial Health — source: SEC EDGAR
Altman Z-Score-4.00 (distress)
Valuation vs Sector & Industry
Stock P/E-5.7
Sector P/E (Healthcare)20.9
Industry P/E (Pharmaceutical Products)17.0
vs Sector-127.5%
vs Industry-133.7%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock Fund Advisors ($8.58M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOYuichi Iwaki
Employees13
CountryUS
IPO Date2006-12-08

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • PMV Pharmaceuticals, Inc. (PMVP)
  • Voyager Acquisition Corp. (VACH)
  • MIRA Pharmaceuticals, Inc. (MIRA)
  • Clene Inc. (CLNN)
  • ALX Oncology Holdings Inc. (ALXO)
  • Metagenomi, Inc. Common Stock (MGX)
  • Cumberland Pharmaceuticals Inc. (CPIX)
  • MAIA Biotechnology, Inc. (MAIA)
MNOV earnings history · MNOV institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.